DETECTION OF BACTERIAL ENDOTOXINS IN DRUGS: DISTURBING FACTORS AND THEIR ELIMINATION
DOI: https://doi.org/None
Issue:
6
Year:
2017
Introduction. It is important to ensure the absence of pyrogenic impurities in the manufacture of parenteral drugs. Control of pharmaceutical substances for bacterial endotoxins is a complex problem with the substances that are poorly water-soluble and/or have obstacles in carrying out the LAL test. Objective: to investigate the influence of the factors that may interfere with the detection of bacterial endotoxins via the gel-clot test, to search, and choose a method that eliminates the disturbing factors. Material and methods. The investigation objects were pharmaceutical substances, such as ascorbic acid and Teraftal, and blood drugs. The LAL-test in the modification of the gel-clot used tris-buffer (Tris-hydroxyethylaminomethyl hydrochloride), magnesium chloride solution, and the specific buffer β-glycan blocker. Results. Procedures were proposed to eliminate the factors interfering with the LAL-test. The most common causes of false results, such as inhibited gel formation due to a wrong pH value or the ability of substances to form complexes, were considered. A decision was proposed to prevent false-positive results in the index “Bacterial endotoxins” in experiments with blood preparations. Conclusion. Approaches to eliminating the influence of disturbing factors on the results of the LAL-test were elaborated.
Keywords:
drugs
pharmaceutical substances
quality
bacterial endotoxins
LAL test
false results
disturbing factors
inhibition
potentiation
References:
- Shapovalova O.V., Dolgova G.V., Neugodova N.P., Sapozhnikova G.A. Ispol`zovanie organicheskih rastvoriteley dlya opredeleniya pokazatelya «Bakterial`nye e`ndotoksiny» v farmacevticheskih substanciyah, ne rastvorimyh v vode. Antibiotiki i himioterapiya, 2013; 58: 41–4.
- Shapovalova O.V., Neugodova N.P., Dolgova G.V., Sapozhnikova G.A. Osobennosti provedeniya razrabotki razdela «Bakterial`nye e`ndotoksiny» dlya substanciy antibiotikov. Antibiotiki i himioterapiya, 2008; 53: 34–8.
- Merkulova Yu.V., Dolgova G.V., Chayka L.A., Gomon O.N., Neugodova N.P., Shapovalova O.V. Osobennosti provedeniya ispytaniya na bakterial`nye e`ndotoksiny lekarstvennyh sredstv v vide maslyanyh rastvorov. Farmakom, 2008; 1: 67–73.
- Shapovalova O.V., Neugodova N.P., Dolgova G.V., Sapozhnikova G.A. Metodicheskie podhody k razrabotke pokazatelya «Bakterial`nye e`ndotoksiny» v farmacevticheskih substanciyah. Vedomosti Nauchnogo centra e`kspertizy sredstv medicinskogo primeneniya. 2012; 3: 47–50.
- Merkulova Yu.V., Chayka L.A., Gomon O.N. Ispol`zovanie bufernyh rastvorov v ispytanii «Bakterial`nye e`ndotoksiny». Farmakom, 2009; 3: 40–8.
- Nagarajan K., Chakraborty Shibu, Chitnis P. K. Inhibition and Enhancement. BET Newsletter A Charles River Private Limited Communication, 2010; 1 (4): 5.
- Low Endotoxin Recovery (LER): A Review. LALUpdate, 2014; 30 (2): 8.
- Sitnikov A.G., Travina L.A., Bagirova V.L. LAL-test. Sovremennye podhody k opredeleniyu pirogennosti. M., 1997; 27–8.
- Hurley, J.C., F.A. Tosolini, W.J. Louis. Quantitative Limulus lysate assay for endotoxin and the effect of plasma. Clin. Pathol, 1991; 44(10): 849–54.
- Nagarajan K., Chitnis P. K. Part II: Enhancement». BET Newsletter A Charles River Private Limited Communication, 2010; 1 (5): 5.
- Gosudarstvennaya farmakopeya Rossiyskoy Federacii XII izd. ch. I. FS 42-0218-07 «Askorbinovaya kislota». M: Nauchnyy centr e`kspertizy sredstv medicinskogo primeneniya, 2007.
- Gosudarstvennaya farmakopeya Rossiyskoy Federacii XIII izd. [E`lektronnyy resurs]. Rezhim dostupa: http://pharmacopoeia.ru/ofs-1-2-4-0006-15-bakterialnye-endotoksiny